These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 25504266

  • 1. Relative cerebral blood volume from dynamic susceptibility contrast perfusion in the grading of pediatric primary brain tumors.
    Ho CY, Cardinal JS, Kamer AP, Kralik SF.
    Neuroradiology; 2015 Mar; 57(3):299-306. PubMed ID: 25504266
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
    Xing Z, You RX, Li J, Liu Y, Cao DR.
    Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
    [Abstract] [Full Text] [Related]

  • 3. Paradoxical perfusion metrics of high-grade gliomas with an oligodendroglioma component: quantitative analysis of dynamic susceptibility contrast perfusion MR imaging.
    Sunwoo L, Choi SH, Yoo RE, Kang KM, Yun TJ, Kim TM, Lee SH, Park CK, Kim JH, Park SW, Sohn CH, Won JK, Park SH, Kim IH.
    Neuroradiology; 2015 Nov; 57(11):1111-20. PubMed ID: 26232204
    [Abstract] [Full Text] [Related]

  • 4. Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.
    Law M, Young R, Babb J, Pollack E, Johnson G.
    AJNR Am J Neuroradiol; 2007 Apr; 28(4):761-6. PubMed ID: 17416835
    [Abstract] [Full Text] [Related]

  • 5. Dynamic contrast-enhanced and dynamic susceptibility contrast perfusion MR imaging for glioma grading: Preliminary comparison of vessel compartment and permeability parameters using hotspot and histogram analysis.
    Santarosa C, Castellano A, Conte GM, Cadioli M, Iadanza A, Terreni MR, Franzin A, Bello L, Caulo M, Falini A, Anzalone N.
    Eur J Radiol; 2016 Jun; 85(6):1147-56. PubMed ID: 27161065
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M, Young R, Babb J, Rad M, Sasaki T, Zagzag D, Johnson G.
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [Abstract] [Full Text] [Related]

  • 12. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S, Oğuz KK, Cila A.
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic accuracy of automatic normalization of CBV in glioma grading using T1- weighted DCE-MRI.
    Sahoo P, Gupta RK, Gupta PK, Awasthi A, Pandey CM, Gupta M, Patir R, Vaishya S, Ahlawat S, Saha I.
    Magn Reson Imaging; 2017 Dec; 44():32-37. PubMed ID: 28827098
    [Abstract] [Full Text] [Related]

  • 14. Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements.
    Friedman SN, Bambrough PJ, Kotsarini C, Khandanpour N, Hoggard N.
    Br J Radiol; 2012 Dec; 85(1020):e1204-11. PubMed ID: 23175486
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M, Frauenfelder G, Senese R, Zeccolini F, Schena E, Giurazza F, Jäger HR.
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.